|
 |
ParaplatinThis page contains recent news articles, when available, and an overview of Paraplatin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Paraplatin (when available) Carboplatin is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death. For the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of PARAPLATIN and cyclophosphamide. Mechanism Of Action: Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. News Articles on Carboplatin Bristol-Myers Cuts 2009 Outlook - Analyst Blog - Dec 24, 2009 Generic competition has resulted in drugs such as Cefzil, Paraplatin, Glucophage, Monopril and Taxol experiencing sales declines. ... Benzinga Combination of Herceptin® with Non-anthracycline-based Chemotherapy Appears to ... - Dec 18, 2009 ...trial (BCIRG 006) have reported that a non-anthracycline-containing chemotherapy regimen utilizing Taxotere® (docetaxel) and Paraplatin® (carboplatin) ... Cancer Consultants SABCS: No Need for Anthracycline with Trastuzumab - Dec 12, 2009 ...docetaxel (Taxotere) -- with the same combination with trastuzumab, and to a third arm of just docetaxel, carboplatin (Paraplatin), and trastuzumab. ... MedPage Today Bristol-Myers Sets Swap Offer Rate - Dec 17, 2009 Generic competition has resulted in drugs such as Cefzil, Paraplatin, Glucophage, Monopril and Taxol experiencing sales declines. ... Zacks.com Amrubicin® and Paraplatin® Active and Tolerable in Elderly Patients with SCLC - Oct 22, 2009 Researchers from Japan have reported Amrubicin®, a new synthetic anthracycline, combined with Paraplatin® (carboplatin) resulted in an 89% overall response ... Cancer Consultants Inflammatory Breast Cancer (IBC) Represents 1-5% Cases In US - Oct 19, 2009 For several weeks, Cristofanilli used a combination of chemotherapy drugs Paraplatin®, Taxotere® and Herceptin® to treat Williams. ... Basil & Spice Tumore polmonare non a piccole cellule, avanzato e non-operabile: la ... - Oct 29, 2009 ...randomizzati di fase II ( n=99 ) e fase III ( n=878 ) sull'uso di Bevacizumab ( Avastin ) più Carboplatino ( Paraplatin ) e Paclitaxel ( Taxol ). ... XagenaSalute India's Sun Pharma gets US nod to sell cancer drug - Sep 23, 2008 Paraplatin injections of 5 ml, 15 ml and 45 ml have annual sales of about $45 million in the United States, Sun Pharma said. ... Reuters Cranberry Could Juice Up Ovarian Cancer Treatment - Aug 21, 2007 All the cancer cells were subsequently treated with paraplatin chemotherapy. The result: Cells pre-treated with the juice extract were killed at a rate that ... Washington Post New Adjuvant Treatment Option for Stage I Seminoma - Jul 21, 2005 Consider Paraplatin-based chemotherapy as an adjuvant treatment following surgery ... Of these, 885 were randomized to radiotherapy and 560 to Paraplatin. ... MedPage Today Velcade® Plus Gemzar®/Paraplatin® Highly Active in Advanced NSCLC - Jun 2, 2006 According to results presented at the 42nd annual meeting of the American Society of Clinical Oncology (ASCO), the treatment combination consisting of ... Cancer Consultants … USFDA Approval to Market Generic Paraplatin(R) Injection. - PR News - Sep 23, 2008 These strengths of Paraplatin(R) Injections have annual sales of approximately ... Paraplatin (R) is a registered trademark of Bristol Myers Squibb Company. ... Pay-Per-View - PR Newswire Europe - HighBeam Research Cranberry Compounds Shown to Improve Effectiveness of Chemotherapy … - Aug 23, 2007 Chemotherapy using platinum drugs, including cisplatin and paraplatin, ... They exposed the cells to the platinum drug paraplatin and compared them to cells ... Food Product Design Avastin Adds Two Months to Lung Cancer Survival - Dec 13, 2006 Patients in the Avastin/Taxol-Paraplatin arm received six cycles of ... Four hundred and seventeen patients from the Avastin/Taxol-Paraplatin arm were ... MedPage Today Bristol's Paraplatin, Bripatin obtain additional indications. - Oct 10, 2005 Paraplatin is now approved for use in the treatment of paediatric malignant solid tumours. The additional indication approved for Briplatin was for ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Spectrum seeks OK for migraine drug - Jan 10, 2005 Included in the roster are carboplatin (generic equivalent of cancer treatment Paraplatin), fluconazole (generic equivalent of yeast infection drug ... Los Angeles Business Business Update; Reports indicate Bristol-Myers may sell its consumer... - Jan 24, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. Its diabetes drug, Glucophage, ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Triple-Chemo Regimen No Improvement in Ovarian Cancer - Aug 1, 2006 They randomized 658 women to six cycles to 10 cycles of Paraplatin-Taxol followed ... Dose reductions were more common in the Paraplatin-Taxol-Hycamtin arm ... MedPage Today GPC Biotech berichtet über die Wahl von Donald Soltysiak in den … - May 25, 2007 Er war für mehrere erfolgreiche Markteinführungen bedeutender Krebsmedikamente verantwortlich, darunter Paraplatin® (Carboplatin) und Taxol® (Paclitaxel). ... pressrelations.de Firm could be ripe for acquisition, analyst says. - Apr. 27, 2005 - Apr 27, 2005 But last year's patent expiration on chemotherapy drug Paraplatin is expected ... Referring to the loss of Paraplatin, a chemotherapy drug with $673 million ... CNNMoney.com Archive for July, 2007 - Jul 5, 2007 The program, which involved 745 patients and combined Alimta with either Platinol or Paraplatin, produced the following results, which were reported at the ... Mesothelioma & Asbestos Awareness Center Bristol-Myers May Be Mulling Drug Line Sale - Jan 5, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. Its diabetes drug, Glucophage, ... FOXNews Chemotherapy combination helpful for elderly with mesothelioma - Jul 21, 2008 The current study evaluated Alimta and Paraplatin in 178 patients with malignant pleural mesothelioma, 48 of whom were 70 years of age or older. ... Mesothelioma News Herceptin Plus Chemotherapy Improves Survival - Jan 26, 2006 TCH arm: Taxotere, Paraplatin (chemical name: carboplatin), and Herceptin, ... In the women who took Taxotere, Paraplatin, and Herceptin (the TCH arm), ... Breastcancer.org Bristol-Myers Profit, Outlook Below Estimates - Oct 28, 2005 Paraplatin sales plunged 76 percent to $42 million. The company's biggest product, Plavix to prevent blood clots, jumped 9 percent to $980 million. ... FOXNews Daily Cancer News - Nov 5, 2007 To explore the safety and efficacy of adding Avastin to chemotherapy with Paraplatin and Camptosar, researchers are conducting a Phase II clinical trial ... Cancer Consultants Cranberries May Improve Chemotherapy for Ovarian Cancer - Aug 13, 2007 Chemotherapy using platinum drugs, including cisplatin and paraplatin, ... Paraplatin killed 6 times more cancer cells that were pre-treated with juice ... newswise.com Bristol-Myers wants to sell Bufferin, Excedrin - Jan 12, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... USA Today Cranberries May Improve Chemotherapy For Ovarian Cancer - Aug 26, 2007 Chemotherapy using platinum drugs, including cisplatin and paraplatin, ... Paraplatin killed 6 times more cancer cells that were pre-treated with juice ... sciencedaily.com Anti-Angiogenic Therapy for Advanced Non-Small Cell Lung Cancer - May 13, 2005 Therefore, the Paraplatin, Taxol and Avastin regimen has now become the new reference standard for future ECOG trials in advanced nonsquamous NSCLC. ... Cancer Consultants Kosan Presents Favorable Data From Two KOS-862 Phase IB … - May 15, 2005 NOTE: Gemzar(R), Paraplatin(R) and Herceptin(R) are registered trademarks of Eli Lilly and Company, Bristol-Myers Squibb Company, and Genentech, Inc., ... RedOrbit Loislaw Federal District Court Opinions - IN RE PHARMACEUTICAL … - Sep 26, 2008 Paraplatin was a patent-protected, single-source drug throughout the class period; Taxol, Vepesid, Cytoxan tablets and Blenoxane began as single-source ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw American Pharmaceutical Partners Receives FDA Approval for … - Feb 17, 2006 Paraplatin(R) is a registered trademark of Bristol-Myers Squibb Company. Contacts: American Pharmaceutical Partners, Inc. Nicole Williams Executive Vice ... RedOrbit Federal Register 2005 - 70 FR 15636 Summaries of Medical and Clinical - Mar 28, 2005 The summaries of medical and clinical pharmacology reviews of pediatric studies conducted for PARAPLATIN (carboplatin), TRUSOPT (dorzolamide), ... Pay-Per-View - Federal Register 2005 - Loislaw Average Increase in Price of Cancer Drugs Below CPI Trend - Oct 9, 2006 Of most significance is the fact that less than 2% of cancer patients receive Hycamtin while 10% receive Paraplatin, which is used for the treatment of a ... Genetic Engineering News - Genetic Engineering News (press release) Arkansas Regulations - 272.113 Chemotherapy Drugs Restricted by … - Apr 2, 2008 Z1848 Tamoxifin 10mg Tab (Nolvadex) J9045 Z1849 Paraplatin (Carboplatin) 150mg J9045 Z1850 Paraplatin (Carboplatin) 450mg S0108 Z1851 Mercaptopurine Tab ... Pay-Per-View - Arkansas Regulations - Loislaw Press Release: Bristol-Myers Squibb Announces Fourth Quarter and … - Jan 27, 2005 Sales of PARAPLATIN(R), an anticancer agent, decreased 87% to $27 million from $204 million in 2003 due to the entry of multiple generic competitors in ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Avastin Used in Combination with Drugs from Bristol- … - Apr 23, 2008 Avastin Used in Combination with Taxol and Paraplatin Will Become the Clinical Gold Standard Treatment by 2011, According to a New Report from Decision ... Pay-Per-View - PR Newswire - HighBeam Research GPC Biotech Announces Election of Donald Soltysiak to Supervisory … - May 25, 2007 He was responsible for several successful product launches of key oncology drugs, including Paraplatin(R) (carboplatin) and Taxol(R) (paclitaxel). ... Genetic Engineering News - Genetic Engineering News (press release) Bristol-Myers selling drug line - Jan 13, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... $2.95 - Deseret News - NewsBank Kidney Drugs Take Stage | Pharmaceuticals News | Print Financial & … - Jun 4, 2006 ...hadn't received chemotherapy, weekly Abraxane and carboplatin, a type of chemo sold under the brand name Paraplatin by Bristol-Myers Squibb (BMY Quote). ... TheStreet.com - TheStreet.com (subscription) Bristol-Myers may sell line of over-the-counter drugs | Article from... - Jan 6, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... Pay-Per-View - Deseret News - HighBeam Research Press Release: GPC Biotech Announces Election of Donald Soltysiak to ... - May 25, 2007 He was responsible for several successful product launches of key oncology drugs, including Paraplatin(R) (carboplatin) and Taxol(R) (paclitaxel). ... Pay-Per-View - PR Newswire - HighBeam Research Bristol-Myers selling drug line | Article from Deseret News (Salt... - Jan 13, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... Pay-Per-View - Deseret News - HighBeam Research Four drug combination helps in lung cancer-US study - Nov 14, 2008 The two older chemotherapy drugs, paclitaxel, sold under the brand name Taxol and carboplatin sold under the brand name Paraplatin, both by Bristol Myers ... Reuters Four drug combination helps in lung cancer-US study - Nov 13, 2008 The two older chemotherapy drugs, paclitaxel, sold under the brand name Taxol and carboplatin sold under the brand name Paraplatin, both by Bristol Myers ... Reuters Kidney Drugs Take Stage - Jun 3, 2006 ...weekly Abraxane and carboplatin, a type of chemo sold under the brand name Paraplatin by Bristol-Myers Squibb (BMY - commentary - Cramer's Take). ... TheStreet.com - TheStreet.com (subscription) Breast Cancer Chemotherapy - Breast Cancer Health Information - NY … - Nov 10, 2008 Platinum-based drugs include oxaliplatin (Eloxatin) and carboplatin (Paraplatin). These drugs may be used in combination regiments for advanced cancer or ... New York Times ASCO unveils latest treatment strategies - May 19, 2005 ...be evaluated in Phase II monotherapy trials in breast and prostate cancer, as well as Phase Ib combination trials with Gemzar, Paraplatin and Herceptin. ... DrugResearcher.com BRISTOL-MYERS PUTS UNIT UP FOR SALE - Jan 16, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... $2.95 - Belleville News-Democrat - NewsBank B-MS posts 3rd-qtr 30% non-GAPP earnings slump on flat sales.(Bristol... - Nov 7, 2005 The latter were impacted by exclusivity losses for the anticancer agent Paraplatin (carboplatin) and Videx (didanosine) and increased competition for ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Lung Cancer - Non-Small Cell Chemotherapy Treatments - Lung Cancer - … - Aug 5, 2008 Most chemotherapy regimens use platinum compounds, either cisplatin (Platinol) or carboplatin (Paraplatin). The preferred regimen uses two drugs -- one of ... New York Times Article: Tue: Whoever loses, Teva wins. - Globes (Tel Aviv, Israel) |... - Aug 22, 2006 Bristol-Myers Squibb's Paraplatin had ... million in 2003. Teva will ... ... Article: Bristol-Myers Squibb Statement on Paraplatin ... ... Pay-Per-View - Globes - HighBeam Research Brain Tumor - Children Chemotherapy - Brain Tumor - Children Health … - Jun 10, 2008 Cisplatin (Platinol) and carboplatin (Paraplatin) are standard cancer drugs that are sometimes used to treat glioma, medulloblastoma, and other types of ... New York Times BUSINESS NEWS IN BRIEF - Oct 10, 2005 Paraplatin received an additional indication for pediatric malignant solid tumors (neuroblastoma, retinoblastoma, hepatoblastoma, CNS germ cell tumors, ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Bristol-Myers puts consumer over-the-counter unit up for sale |... - Jan 16, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... Pay-Per-View - AP Worldstream - HighBeam Research Bristol-Myers puts consumer over-the-counter unit up for sale |... - Jan 12, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... Pay-Per-View - AP Worldstream - HighBeam Research Business Update; Reports indicate Bristol-Myers may sell its consumer... - Jan 28, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. Its diabetes drug, Glucophage, ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Reports: Bristol-Myers in Drug Sale Talks | Article from AP Online | ... - Jan 5, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... Pay-Per-View - AP Online - HighBeam Research Business Update; Reports indicate Bristol-Myers may sell its consumer... - Jan 25, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. Its diabetes drug, Glucophage, ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Reports: Bristol-Myers Considers Drug Sale | Article from AP Online |... - Jan 5, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. Its diabetes drug, Glucophage, ... Pay-Per-View - AP Online - HighBeam Research Bristol-Myers Puts Drug Line Up for Sale | Article from AP Online | … - Jan 12, 2005 Bristol-Myers also sells cholesterol drug Pravachol, blood thinner Plavix, and cancer treatment Paraplatin. The company's diabetes drug, Glucophage, ... Pay-Per-View - AP Online - HighBeam Research Article: Barr Pharmaceuticals and its subsidiary PLIVA announced that... - Jan 1, 2007 Article: Bristol-Myers Squibb Statement Regarding Paraplatin ... PR Newswire; March 31, 2004 ; 700+ words ...Bristol-Myers Squibb Company reported today . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Ovarian Cancer Medications - Ovarian Cancer Health Information - NY … - Dec 24, 2008 A platinum-based drug, such as carboplatin (Paraplatin) or cisplatin (Platinol). Carboplatin is preferred over cisplatin in the combination. ... New York Times BRIEFLY; Cranberry juice may boost chemo - Aug 27, 2007 Ovarian cancer, the fifth-leading cause of cancer death among U.S. women, became as much as six times more sensitive to the chemotherapy drug paraplatin ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Equities firm: Sterlite, HDFC Bank top gainers - Sep 24, 2008 Sun Pharmaceutical shares were up 2.12 per cent after USFDA granted approval for Abbreviated New Drug Application to market generic Paraplatin, ... Times of India 3 drug cos. post 2nd-quarter profit gains - Jul 28, 2005 Revenue from diabetes drug Glucovance dropped 74 percent to $12 million, while cancer drug Paraplatin sales plunged 86 percent to $33 million. ... MLive.com FDA Gives Avastin First-Line NSCLC Indication - Oct 12, 2006 ROCKVILLE, Md., Oct. 12 -- The FDA has approved Avastin (bevacizumab), in combination with Taxol (paclitaxel) and Paraplatin (carboplatin), as first-line ... MedPage Today Bristol-Myers Net Drops | Robert Steyer | Financial Articles &... - Apr 28, 2005 Big sales declines were posted by the oncology drugs Taxol, down 16% to $205 million, and Paraplatin, down 81% to $44 million. But sales of Bristol-Myers ... TheStreet.com - TheStreet.com (subscription) DRUG CAPSULE WHAT YOU SHOULD KNOW - Sep 11, 2006 Interactions: Tell your doctor and pharmacist if you are allergic to cisplatin or any other platinum-containing compounds, such as carboplatin (Paraplatin, ... $2.95 - Milwaukee Journal Sentinel - NewsBank Indian Stocks Rise; Reliance, Equipment Makers, Sterlite Gain - Sep 24, 2008 ...s Paraplatin injection for treating ovarian cancer. Tata Motors Ltd. (TTMT IN) fell 6.2 rupees, or 1.6 percent, to 387.50. The automaker, which is making ... Bloomberg DRUG CAPSULE WHAT YOU SHOULD KNOW | Article from The … - Sep 11, 2006 Interactions: Tell your doctor and pharmacist if you are allergic to cisplatin or any other platinum-containing compounds, such as carboplatin (Paraplatin, ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Bristol-Myers net income sinks while AstraZeneca earnings jump - Jan 27, 2005 The company continues to feel the sting from the loss of patent exclusivity on blood pressure medication Monopril, cancer agent Paraplatin and its ... San Diego Union - Tribune - San Diego Union Tribune Research and Markets: Injectable Generic Drugs: Prospects & - Jul 25, 2008 For example, when Bristol-Myers Squibb's Paraplatin (carboplatin) became generically available 11 companies received FDA approval for generic versions. Bloomberg Merck hurt by Vioxx, but Pfizer a safe bet, analysts say. - Jul. 19,... - Jul 19, 2005 Analysts say that Bristol's poor performance for the quarter stems from declining Pravachol sales, combined with generic pressures to Paraplatin and Taxol, ... CNNMoney.com 港医å¦ä¸“家：肺癌患者手术å?Žåº”接å?—化疗 - Nov 3, 2008 ...但癌症å?Šè¡€ç™Œç ”究组织(CALGB)于1996年至2003å¹´å?¬é›†344å??第1æœŸè‚ºç™Œæ‚£è€…ç ”ç©¶ï¼Œå?Šæ•°äºº ä¾?ç…§ä¼ ç»Ÿæ²»ç–—æŒ‡å¼•ï¼Œå?Šæ•°åˆ™åœ¨æ‰‹æœ¯å?ŽæŽ¥å?—12周的紫æ?‰é†‡(Taxol)å’Œå?¡é“‚(Paraplatin)é’ˆè?¯ ... 人民网 IASLC: Third-Generation Chemotherapeutics Improve Survival in Real- … - Sep 5, 2007 ...also includes gemcitabine (Gemzar) and docetaxel (Taxotere), used for this patient population, typically in combination with carboplatin (Paraplatin). ... MedPage Today 美国制è?¯ç¬¬å››å£å‡€æ‰€å¾—增长7% - Feb 18, 2006 Carboplatin是必治妥施贵å®?(BMY)å?µå·¢ç™Œè?¯ç‰©Paraplatin的一ç§?仿制产å“?。 在今晨公布的 财政报告ä¸ï¼Œè¿™å®¶ä»¿åˆ¶è?¯åˆ¶é€ 商指出，全å£å‡€æ‰€å¾—增至2340万美元，å?³æ¯?股盈利32美 ... 新浪网 港醫å¸å°ˆå®¶ï¼šè‚ºç™Œæ‚£è€…手術å?Žæ‡‰æŽ¥å?—化療 - Nov 3, 2008 ...但癌症å?Šè¡€ç™Œç ”究組織(CALGB)æ–¼1996年至2003å¹´å?¬é›†344å??第1æœŸè‚ºç™Œæ‚£è€…ç ”ç©¶ï¼Œå?Šæ•¸äºº ä¾?照傳統治療指引，å?Šæ•¸å‰‡åœ¨æ‰‹è¡“å?ŽæŽ¥å?—12周的紫æ?‰é†‡(Taxol)å’Œå?¡é‰‘(Paraplatin)é‡?è—¥ ... 人民网 Genentech and Roche's Avastin shows further survival benefit - Mar 15, 2005 It evaluated Avastin (bevacizumab) plus paclitaxel (Bristol-Myers Squibb's Taxol) and carboplatin (Bristol-Myers Squibb's Paraplatin) chemotherapies in ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Hope After Cancer Relapse - Jul 27, 2007 Study authors write the disease is curable when patients are given carboplatin (Paraplatin) chemo at five-times the level given to men initially treated for ... Ivanhoe Broadcast News SABCS: Anthracycline May Be Superfluous in Breast Cancer Regimens - Dec 15, 2006 The patients were randomized to receive adjuvant therapy consisting of Herceptin-Paraplatin-Taxotere or Adriamycin-Cytoxan-Taxotere-Herceptin or the control ... MedPage Today DELTA REPORTS RECORD FARE SALES - Jan 13, 2005 Bristol-Myers also sells the cholesterol drug Pravachol, blood thinner Plavix and cancer treatment Paraplatin. Kraft Foods Inc., the nation's biggest food ... $2.95 - Lexington Herald Leader - NewsBank Lung Cancer is the Third Most Common Malignant Disease and the First ... - May 11, 2007 ...drugs go off patent before 2012; Aventis' Taxotere (docetaxel), Bristol-Myers Squibb's Paraplatin (carboplatin) and Eli Lilly's Gemzar (gemcitabine). ... Genetic Engineering News - Genetic Engineering News (press release) 制è?¯å·¨å¤´æ–½è´µå®?å…¬å?¸æ‹Ÿå‡ºå”®é?žå¤„æ–¹è?¯ä¸šåŠ¡ - Jan 11, 2005 ...å°¿ç—…è?¯ç‰©paraplatinå’Œglucophageæœ€è¿‘å› ä¸ºå¤±åŽ»ä¸“åˆ©ä¿?护而销é‡?é”?å‡?。 《纽约时报》é€?露， 总部ä½?äºŽè‹±å›½çš„è‘›å…°ç´ å?²å…‹å…¬å?¸å’Œä¸€äº›ç§?人投资公å?¸æœ‰æ„?收è´æ–½è´µå®?çš„é?žå¤„æ–¹è?¯ ... 新浪网 Coughing Is Bad for Amgen's Health - Nov 21, 2008 The trial was testing motesanib in combination with generic versions of Bristol-Myers Squibb's (NYSE: BMY) Taxol and Paraplatin in non-small cell lung ... fool.com Tre läkare varnas efter pojkes död - Sep 9, 2008 Enligt HSAN överdoserades pojken kraftig med cancerläkemedlet Paraplatin. Läkarna saknade kunskaper om hur läkemedlet skulle doseras och pojken fick därför ... Sveriges Radio Adjuvant and Neoadjuvant Chemotherapy for Breast Cancer - Dec 8, 2005 Paraplatin® (carboplatin) and Taxotere were administered with concurrent Herceptin (TCH) followed by Herceptin to complete one full year of therapy. ... Cancer Consultants Spectrum Pharmaceuticals Inc added to watchlist. - Dec 6, 2006 So far it has acquired rights to knock-offs of Bayer's Cipro antibiotic, Pfizer's Diflucan anti-fungal agent, Bristol-Myers Squibb's Paraplatin ovarian ... Free with registration - M2 Presswire - AccessMyLibrary.com FDA Warns of Possible Bevacizumab Fistula Complication - Apr 23, 2007 ...which was closed to new accruals on March 12, combined four cycles of concurrent irinotecan (Campto), carboplatin (Paraplatin), radiation therapy, ... MedPage Today Chemoradiation can boost lung cancer survival: locally advanced, … - May 1, 2005 Carboplatin (Paraplatin) is included in combination with paclitaxel (Taxol) as an alternative to current combination regimens based on cisplatin (Platinol) ... Free with registration - Internal Medicine News - AccessMyLibrary.com Bellwether Report.com is Tracking Spectrum Pharmaceuticals Inc. - Sep 25, 2006 So far it has acquired rights to knock-offs of Bayer's Cipro antibiotic, Pfizer's Diflucan anti-fungal agent, Bristol-Myers Squibb's Paraplatin ovarian ... Free with registration - M2 Presswire - AccessMyLibrary.com CTS: Proton Therapy Reduces Bone Marrow Toxicity in Lung Cancer … - Nov 18, 2008 Similar percentages of patients underwent induction chemotherapy and most of the patients were treated with a combination of carboplatin (Paraplatin) and ... MedPage Today Spectrum Pharmaceuticals Completes Enrollment in EOquin(TM) Multi- … - Jan 6, 2005 In addition, the Company has five Abbreviated New Drug Applications for carboplatin (generic equivalent of Paraplatin(R)), fluconazole (generic equivalent ... RedOrbit ASCO: No NSCLC Survival Benefit with Neoadjuvant Chemotherapy - Jun 4, 2007 ...vinorelbine (Navelbine); paclitaxel (Taxol) and carboplatin (Paraplatin); cisplatin and gemcitabine (Gemzar); or docetaxel (Taxotere) and carboplatin. ... MedPage Today SPPI Announces Alliance With Cura Pharmaceuticals - Apr 14, 2005 The exclusivity for Paraplatin®, the branded form of carboplatin marketed by Bristol Myers Squibb, expired in 2004 and generic versions of the product have ... StreetInsider.com - StreetInsider.com (subscription) Introgen's Novel P53 Cancer Vaccine Sensitizes Tumors to Platinum and... - May 16, 2005 Platinum, Taxanes and Doxorubicin are widely employed drugs in the treatment of cancer that include Platinol (cisplatin) and Paraplatin (carboplatin) ... RedOrbit IASLC: Hopes Dashed for Thalidomide for SCLC - Sep 6, 2007 It included 724 patients at 79 British centers randomized to receive up to six three-week courses of etoposide and carboplatin (Paraplatin) with placebo or ... MedPage Today Between 2010 and 2015 the therapeutic lung cancer drug market is … - Mar 23, 2006 Aventis Taxotere (docetaxel), Bristol-Myers Squibbs Paraplatin (carboplatin) and Eli Lillys Gemzar (gemcitabine). The third-generation chemotherapeutic ... Free with registration - M2 Presswire - AccessMyLibrary.com Dr. Alex Giaquinto Joins Biothera Board of Directors - Jun 9, 2008 A trial in lung cancer patients receiving Imprime PGG, Avastin(R) (bevacizumab) and two chemotherapy drugs -- Taxol (paclitaxel) and Paraplatin ... RedOrbit NCCN Announces Important Updates to Ovarian Cancer Clinical Practice ... - Mar 6, 2006 The regimens include gemcitabine (Gemzar, Lilly)/carboplatin (Paraplatin, Bristol Myers-Squibb) and carboplatin/paclitaxel (Taxol, Bristol Myers-Squibb). ... Free with registration - Business Wire - AccessMyLibrary.com Polysaccharide combats cancer drug resistance - May 23, 2005 Aventis's Taxotere patent expires in 2007 in Europe and in 2010 in the United States; Bristol-Myers Squibb's Paraplatin patent expires in 2004 in the United ... DrugResearcher.com Genentech/Roche's Avastin will be Primary Driver of Ovarian Cancer … - Oct 25, 2005 ...the current gold-standard therapy of carboplatin (Bristol-Myers Squibb's Paraplatin, generics) combined with paclitaxel (Bristol-Myers Squibb's Taxol, ... Free with registration - PR Newswire - AccessMyLibrary.com Ovarian Cancer Drug Combination Identified at Rational Therapeutics … - Jul 28, 2006 The activity for Cisplatin and its derivative Carboplatin (Paraplatin, Bristol Meyers Squibb) plus the pancreatic cancer drug Gemcitabine (Gemzar, ... Free with registration - Business Wire - AccessMyLibrary.com Lung Cancer Drug Pipeline Update Lists All 243 Drugs for Lung Cancer ... - Feb 16, 2006 ...drugs go off patent before 2012, Aventis' Taxotere (docetaxel), Bristol-Myers Squibb's Paraplatin (carboplatin) and Eli Lilly's Gemzar (gemcitabine). ... RedOrbit Kosan provides update on KOS-862 Phase II programme. - Oct 18, 2005 ...monotherapy trial in breast cancer, Roche and Kosan are evaluating KOS-862 in three Phase Ib combination studies with Gemzar, Paraplatin and Herceptin. ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com IASLC: Pemetrexed-Platinum Duo Called Preferred First-Line Regimen … - Sep 5, 2007 ...there were no overall differences in outcomes between pemetrexed and gemcitabine in combination with carboplatin (Paraplatin) in one trial and cisplatin ... MedPage Today Brand Names/Synonyms: Paraplatin is also known by the following brand names and/or synonymsCbdca; Carboplatin (USAN); cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II); Platinum(II), (1, 1-cyclobutanedicarboxylato)diammine-, cis-; Platinum, {diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-,} (SP-4-2)-; Platinum, diamine(1, 1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-; Paraplatin; Paraplatin-AQ Drug Category: Paraplatin is categorized under the following by the FDA: Antineoplastic Agents; ATC:L01XA02 Dosage Forms: SOLUTION Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: platinum;cyclobutane-1,1-dicarboxylicacid;azanide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |